NEW YORK, NY / ACCESS Newswire / February 20, 2025 / If you suffered a loss on your Cardlytics, Inc. (NASDAQ:CDLX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:

You might also be interested in reading Social Media Metrics Show Fantom’s August Price Increase is Likely Influenced by New Users.